Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-21-025783

President & CEO acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
USMAN NASSIM President & CEO 2021-04-05 Option exercise +5,000 $4.63 $23,150 17,174 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
USMAN NASSIM President & CEO 2021-04-05 Option exercise · Stock Option (Right to Buy) −5,000 259,783 D: show line 2 in the form
Loading xslF345X03/doc4.xml…